Metreton

Pemphigus, Ophthalmia, Sympathetic, Chorioretinitis + 95 more

Treatment

55 FDA approvals

20 Active Studies for Metreton

What is Metreton

Prednisone

The Generic name of this drug

Treatment Summary

Diphenhydramine is an antihistamine medication used to treat allergies, hay fever, and asthma. It is commonly used to reduce the symptoms of itching, sneezing, and runny nose. It is less likely to cause drowsiness than other similar medications and is often used in veterinary medicine.

PredniSONE

is the brand name

image of different drug pills on a surface

Metreton Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

PredniSONE

Prednisone

1972

681

Approved as Treatment by the FDA

Prednisone, commonly known as PredniSONE, is approved by the FDA for 55 uses which include Mycosis Fungoides (MF) and Disseminated tuberculosis .

Mycosis Fungoides (MF)

Helps manage Mycosis Fungoides (MF)

Disseminated tuberculosis

Used to treat Disseminated tuberculosis in combination with Aminosalicylic acid

Anemia, Hemolytic

Allergic Rhinitis (AR)

Helps manage Allergic Rhinitis (AR)

Uremia

Thrombocytopenia

Conjunctivitis

Helps manage Ocular Inflammation

Secondary thrombocytopenia

Diuresis

non-suppurative Thyroiditis

Primary adrenocortical insufficiency

Adrenal Cortex Hormones

Helps manage unresponsive to topical corticosteroids

acquired immune hemolytic anemia

Crohn Disease

Helps manage acute Crohn's Disease (CD)

Atopic Dermatitis

Helps manage Atopic Dermatitis

Congenital Hypoplastic Anemia

Congenital Adrenal Hyperplasia (CAH)

Neurologic Involvement

Immune Thrombocytopenia (ITP)

Drug hypersensitivity reaction

Contact Dermatitis

Mycosis Fungoides

Helps manage Mycosis Fungoides (MF)

Thyroiditis

Ulcerative Colitis

Helps manage Ulcerative Colitis

Sarcoidosis

Helps manage symptomatic Sarcoidosis

Secondary adrenocortical insufficiency

Malignant Neoplasms

Stevens-Johnson Syndrome

induction of Diuresis

Idiopathic Nephrotic Syndrome

symptomatic Sarcoidosis

Helps manage symptomatic Sarcoidosis

Asthma

Helps manage Asthma

Ulcerative Colitis

Helps manage Ulcerative Colitis

Ocular Inflammation

Helps manage Ocular Inflammation

Pemphigus

Helps manage Pemphigus

Trichinosis

Pemphigus

Helps manage Pemphigus

Systemic Lupus Erythematosus (SLE)

Adrenal Insufficiency

Addison Disease

Lupus Erythematosus

Proteinuria

Uremia

Bullous dermatitis herpetiformis

Helps manage Bullous dermatitis herpetiformis

Tuberculosis

Used to treat fulminating Tuberculosis in combination with Aminosalicylic acid

Serum Sickness

exfoliative erythroderma

Helps manage exfoliative erythroderma

Anemia, Diamond-Blackfan

Lupus

Congenital adrenal hyperplasia

Patient Participation

Tuberculosis

Used to treat Disseminated tuberculosis in combination with Aminosalicylic acid

Aspiration Pneumonitis

Drug Allergy

Asthma

Helps manage Asthma

Effectiveness

How Metreton Affects Patients

Allergies happen when an allergen (like pollen) interacts with and activates the antibodies on mast cells and basophils. This causes these cells to release histamine and other chemical mediators, which can cause itching, flushing, headaches, a racing heart rate, and other symptoms. Chlorpheniramine is a drug that works by blocking the histamine receptors in the body, which helps to reduce the symptoms of allergies like sneezing, runny nose, itchy eyes, and watery eyes.

How Metreton works in the body

Chlorpheniramine blocks the effects of histamine, which reduces the symptoms of allergies. It does this by attaching to the histamine H1 receptor and preventing it from responding to histamine.

When to interrupt dosage

The suggested measure of Metreton depends upon the determined condition, including upper respiratory indications, Coughing and Inflammation. The amount of dosage is contingent upon the administration technique (e.g. Kit; Syrup - Oral or Liquid - Oral) featured in the table beneath.

Condition

Dosage

Administration

Dermatomyositis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

prophylaxis of graves ophthalmopathy

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Craniotomy

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

exfoliative erythroderma

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Addison Disease

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

varicella-zoster virus acute retinal necrosis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Psoriasis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Trichinosis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

induction of Diuresis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Diuresis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Sarcoidosis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Brain

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Brain

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Optic Neuritis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Congenital adrenal hyperplasia

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Malignant Neoplasms

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

HIV Positive

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Red-Cell Aplasia, Pure

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Psoriatic Arthritis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Ulcerative Colitis

, 5.0 mg/mL, 2.5 mg, 10.0 mg, 5.0 mg, 20.0 mg, 1.0 mg, 50.0 mg, 0.2 mg, 0.1 mg, 2.0 mg/mg, 2.0 mg, 5.0 mg/mg

, Oral, Solution, Solution - Oral, Tablet - Oral, Tablet, Solution, concentrate - Oral, Tablet, delayed release - Oral, Tablet, delayed release, Kit, Solution, concentrate

Warnings

Metreton Contraindications

Condition

Risk Level

Notes

Mycoses

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Prednisone may interact with Pulse Frequency

There are 20 known major drug interactions with Metreton.

Common Metreton Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Prednisone is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Prednisone is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abatacept

Major

The risk or severity of adverse effects can be increased when Prednisone is combined with Abatacept.

Abetimus

Major

The risk or severity of adverse effects can be increased when Prednisone is combined with Abetimus.

Acteoside

Major

The risk or severity of adverse effects can be increased when Prednisone is combined with Acteoside.

Metreton Toxicity & Overdose Risk

The lowest toxic dose of the drug for rats, mice, and guinea pigs has been found to be 306mg/kg, 130mg/kg, and 198mg/kg, respectively. It can also cause mild reproductive harm to women of childbearing age.

image of a doctor in a lab doing drug, clinical research

Metreton Novel Uses: Which Conditions Have a Clinical Trial Featuring Metreton?

163 active trials are currently underway to evaluate the potential of Metreton to reduce Allergy symptoms from vaccines, Eye issues, and Coughing.

Condition

Clinical Trials

Trial Phases

Drug Allergy

2 Actively Recruiting

Phase 3, Phase 2

Asthma

87 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Tuberculosis

0 Actively Recruiting

Relapsing Polychondritis

1 Actively Recruiting

Phase 2

Giant Cell Arteritis

2 Actively Recruiting

Phase 1, Phase 2, Phase 3

Lupus

65 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 3, Phase 4, Early Phase 1

Tennis Elbow

0 Actively Recruiting

Acute Coryza

0 Actively Recruiting

Ulcerative Colitis

17 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable, Phase 4

Bell Palsy

0 Actively Recruiting

Polymyalgia Rheumatica

3 Actively Recruiting

Phase 3, Phase 2

Patient Participation

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Chorioretinitis

0 Actively Recruiting

Acne Vulgaris

3 Actively Recruiting

Phase 1, Phase 2, Early Phase 1, Phase 4

Brain

7 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Early Phase 1

acute Bursitis

0 Actively Recruiting

Brain

0 Actively Recruiting

Arthritis, Juvenile

1 Actively Recruiting

Not Applicable

Bullous dermatitis herpetiformis

0 Actively Recruiting

Metreton Reviews: What are patients saying about Metreton?

5

Patient Review

11/4/2022

Metreton for Depression

This medication has been a lifesaver for me. I've been taking it for anxiety and depression for about a year now, and it really makes a difference. It calms my mind and allows me to get a good night's sleep, which is something that was previously impossible for me. If you're struggling with anxiety, I would highly recommend giving this treatment a try.

5

Patient Review

10/11/2022

Metreton for Depression

I'm 82 years old and have battled depression my entire life. This medication has made me feel incredible, and I would recommend it to anyone. Thank you, Mirtazapine!

5

Patient Review

11/4/2022

Metreton for Depression

I've been taking 7.5mg of this medication for about a year to help with anxiety and mild depression. It definitely takes the edge off and helps me sleep at night, which is amazing. I would recommend it to anyone struggling with similar issues.

5

Patient Review

10/11/2022

Metreton for Depression

I am an 82 year old woman who has struggled with depression for my entire life. This medication has made me feel better than ever before and I would recommend it to anyone. Thank you Mirtazapine!

5

Patient Review

11/4/2022

Metreton for Depression

This dosage of medication has really helped me to cope with my anxiety and depression. It doesn't make me drowsy, but rather allows me to wake feeling refreshed after a good night's sleep. I recommend giving it a try if anxiety is keeping you up at night.

5

Patient Review

10/11/2022

Metreton for Depression

As an 82 year old woman who has dealt with depression my entire life, this treatment was a godsend. I would recommend it to anyone else in a similar situation.

4.7

Patient Review

9/26/2022

Metreton for Depression

I've been using mirtazapine for a while now and it's helped me a lot with depression, anxiety, and insomnia. Recently though, I think it might be causing me to have nightmares every night. Not sure if it's just losing some effectiveness after long-term use or what, but I'm going to keep an eye on it and maybe switch to something else if things get worse.

4.7

Patient Review

9/26/2022

Metreton for Depression

I've been taking mirtazapine for four years now, and it's done a great job treating my depression, anxiety, and insomnia. Recently, though, I think it's been giving me nightmares every night. Not sure if it's just because I've been on the medication for awhile or what, but if this keeps up I might have to switch to something else.

4.7

Patient Review

9/26/2022

Metreton for Depression

I've been taking mirtazapine for four years now and it's done wonders for my depression, anxiety, and insomnia. Recently, however, I think it's started giving me nightmares every night. Not sure why that is, but it's becoming a bit of a problem. Might try something else if things don't improve soon.

4.3

Patient Review

10/20/2022

Metreton for Major Depressive Disorder

It made me really hungry at first, but that side effect dissipated after about a month. It's helped me sleep and takes the edge off my symptoms. Overall, I'm happy with it!

4.3

Patient Review

10/20/2022

Metreton for Major Depressive Disorder

It made me really hungry at first, but that went away after a month. This medication helps me sleep and takes the edge off my symptoms. I'm generally happy with it!

4.3

Patient Review

10/20/2022

Metreton for Major Depressive Disorder

I was really hungry when I first started taking this medication, but that side effect subsided after a month or so. It's helped me sleep and makes my symptoms more manageable. All in all, I'm pretty happy with it!

4

Patient Review

10/4/2022

Metreton for Major Depressive Disorder

Mirtazapine was prescribed to me for my depression. I found that it really helped with my anxiety and insomnia, but after a month it didn't do anything for my depression. It's a powerful pill, but it just wasn't the right one for me.

4

Patient Review

8/18/2022

Metreton for Depression

This medication has been really helpful to me. I only use 7.5 mg, which is half the recommended dosage, but it does the trick!

4

Patient Review

10/4/2022

Metreton for Major Depressive Disorder

Mirtazapine was prescribed to me for my depression. I had no other side effects than the common sedative affect, which is good. It completely took away all my anxiety and insomnia, but after over a month it did nothing for my depression.

4

Patient Review

10/4/2022

Metreton for Major Depressive Disorder

Mirtazapine was prescribed to me for my depression. I experienced the common sedative effect, but it was otherwise unnoticeable. It helped with my anxiety and insomnia, but after a month it had no effect on my depression.

4

Patient Review

8/18/2022

Metreton for Depression

This has been a great help to me. I only use 7.5 mg, half of what my doctor prescribed, and it works perfectly.

4

Patient Review

8/18/2022

Metreton for Depression

I only use half the recommended dosage, but it still does wonders for me. Really happy with this medication.

1.7

Patient Review

9/13/2022

Metreton for Depression

I was prescribed this for depression, anxiety and insomnia. Unfortunately, after taking just one pill I felt incredibly drugged the next morning. I still don't feel normal days later. Needless to say, I won't be taking this again.

1.7

Patient Review

9/13/2022

Metreton for Depression

I was prescribed this for depression, anxiety and insomnia. I took one pill before bed, but instead of feeling sleepy, I felt completely drugged and awake. This continued all night, and the next day I felt nauseous and dizzy. I couldn't function at all. Two days later and I still don't feel normal. Needless to say, I won't be taking this again!

1.7

Patient Review

9/13/2022

Metreton for Depression

I was prescribed this for depression, anxiety, and insomnia. However, after taking just one pill of 15mg around 11:45 pm, I found myself still awake at 4 am. I felt jittery and drugged; it was awful. In addition, the following day I felt completely exhausted, dizzy, and nauseous—I couldn't function at all. Two days later and I still don't feel normal. Needless to say, I won't be taking this again.

1

Patient Review

8/13/2022

Metreton for Major Depressive Disorder

Out of the six other medications I've tried, this one was by far the worst. It made everything more overwhelming and increased my suicidal thoughts and intentions. Unless you have tried other medications beforehand, take this with extreme caution if at all. I would not recommend it whatsoever.

1

Patient Review

8/13/2022

Metreton for Major Depressive Disorder

This medication made everything worse and actually increased my suicidal thoughts. I would not recommend it to anyone.

1

Patient Review

8/13/2022

Metreton for Major Depressive Disorder

I've tried other medications before and this one is by far the worst. It made everything more overwhelming and increased my suicidal thoughts. I wouldn't recommend it to anyone.

Patient Q&A Section about metreton

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Clinical Trials for Metreton

Image of McMaster Children's Hospital - Digestive Diseases Clinic in Hamilton, Canada.

Vancomycin for Ulcerative Colitis

18+
All Sexes
Hamilton, Canada

This clinical trial tests if oral vancomycin can safely treat active ulcerative colitis (UC) in adults who also have primary sclerosing cholangitis (PSC), a liver condition. The main questions it aims to answer are: * Can oral vancomycin improve UC symptoms as measured by Mayo score at 4 weeks? * Is oral vancomycin safe and tolerable in this patient group? Participants will be compared to see if vancomycin works better than placebo. Participants will: * Take oral vancomycin (250 mg twice daily) or identical placebo capsules for 4 weeks * Have the option for 4 more weeks of open-label vancomycin after the blinded phase * Attend clinic visits at baseline, week 4, and follow-up for Mayo scoring, endoscopy, blood/stool tests, and safety checks * Track treatment adherence and side effects The study primarily assesses if the trial can recruit 14 participants, retain them, achieve good adherence, and follow protocol procedures (feasibility). Secondary goals include safety (adverse events) and early signs of benefit in UC activity, liver tests, and gut bacteria balance. This pilot will guide larger future studies.

Phase 2
Waitlist Available

McMaster Children's Hospital - Digestive Diseases Clinic

Neeraj Narula, MD

Image of McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital in Montreal, Canada.

Systemic Corticosteroids for Pneumocystis Pneumonia

18+
All Sexes
Montreal, Canada

The HOW LONG trial is an international, multicenter, Phase IV randomized clinical trial evaluating the optimal duration of adjunctive systemic corticosteroids in immunocompromised adults with severe Pneumocystis jirovecii pneumonia (PCP) who demonstrate early clinical recovery. Participants who no longer require supplemental oxygen by day 10 of corticosteroid therapy are randomized to discontinue corticosteroids at day 10 (or hospital discharge, if earlier) versus continue corticosteroids for a total of 21 days. The trial assesses whether earlier discontinuation reduces steroid-related complications while maintaining clinical outcomes.

Phase 4
Waitlist Available

McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital

Have you considered Metreton clinical trials?

We made a collection of clinical trials featuring Metreton, we think they might fit your search criteria.
Go to Trials

Have you considered Metreton clinical trials?

We made a collection of clinical trials featuring Metreton, we think they might fit your search criteria.
Go to Trials

Have you considered Metreton clinical trials?

We made a collection of clinical trials featuring Metreton, we think they might fit your search criteria.
Go to Trials